| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |